Skip to main content

What the FDA labels say about taking them together

Epinephrine and iodixanol

Iodixanol's FDA label of October 10, 2025 names epinephrine in its drug interactions section; the epinephrine labels PlainMeds reads (4) do not name iodixanol. The iodixanol label: “… reduces the responsiveness of treatment of hypersensitivity reactions with epinephrine.”

Check it at the source: the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions); the iodixanol FDA label on DailyMed (effective October 10, 2025, GE Healthcare Inc.).

What does the epinephrine label say about iodixanol?

Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name iodixanol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed

What does the iodixanol label say about epinephrine?

Iodixanol label, drug interactions

Beta-adrenergic Blocking Agents The use of beta-adrenergic blocking agents lowers the threshold for and increases the severity of contrast reactions, and reduces the responsiveness of treatment of hypersensitivity reactions with epinephrine.

Source: FDA drug label (Visipaque), GE Healthcare Inc., effective October 10, 2025 (SPL set e9d87b8c-7695-4c0f-8e81-000dedb5f66d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Epinephrine generic labelers
1Iodixanol generic labelers
EpinephrineIodixanol
Labeled forAsthman/a
Boxed warningNoYes
Pharmacy cost (NADAC)$123.51 per unit 0.15 mg auto-injctn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?